Market Access

Market access is an important part in the chain of approval of a drug and for market success. Here, different target groups learn what they need to know in order to understand relationships, to act professionally correctly and to negotiate in the best possible way. Thanks to his many years of experience, Lothar Flessau can illustrate both the large and the important small connections.

External sales

  • Basics of statutory health insurance (GKV) - SGB V: Terms and definitions: economic efficiency requirement, drug guidelines and their implementation, test methods
  • (Expenditure) statistics in the GKV and their (meaning) meanings
  • Basics and control instruments in statutory health care and agreements
    a) at the federal level
    b) at regional (KV) level
  • Reforms of the health system, including (early) benefit assessment of drugs (AMNOG) and their effects

Market access / onboarding of new employees

  • Healthcare Actors
  • Healthcare committees / self-government
  • Basics for statutory medical care
  • Contract types (e.g. discount contracts, selective contracts, risk-share contracts)
  • (Expenditure) statistics in the GKV and their (meaning) meanings
  • Reforms of the health system, including (early) benefit assessment of drugs (AMNOG) and their effects

Doctors: the doctor in the field of health policy

Doctors who are about to set up a branch or who are planning to do so:
  • General description of the health policy contexts ("How does the health system work?")
  • Description and tasks of the partners in self-administration (e.g. KVen and cost bearers, medical service of health insurance (MDK), Federal Joint Committee (G-BA), etc.
  • Basics of contractual relationships
  • Contract types (e.g. discount contracts, selective contracts, risk-share contracts)
  • (Expenditure) statistics in the GKV and their (meaning) meanings
  • Reforms of the health system, including (early) benefit assessment of drugs (AMNOG) and their effects
  • Basics of the economic efficiency requirement according to §§ 2, 12 and 70SGB V - What is it actually?
  • Why is documentation so important?
  • How should it be documented? - Tips for everyday practice

Doctors who have been practicing for a long time:
  • Instructions for handling information letters (health insurance companies,KVen, test centers, etc.)
  • Information, knowledge, handling and implementation of regional agreements
  • Notes on the organization of the practice (especially in the direction of Documentation)
  • References to the legal problems with ongoing proceedings
  • Optionally also content from the above-mentioned topics

consultation

Of course, we also offer tailor-made advice on current topics.

useful information

  • Your Pharma-LOT: Lothar Flessau
  • Max. Number of participants: 9
  • Dates by arrangement
  • Individual content, adapted to your needs
  • Requirements: laptop / iPad, headset, internet
  • Confirmation of participation
Request an individual offer

Market Access, a key component in the success of drugs.

Share by: